A novel endogenous mediator of cutaneous inflammation: Leukemia inhibitory factor

Acta Dermato-Venereologica

Volumn 76, Issue 2, 1996, Pages 111-114

  Mckenzie, Roderick C ^a   Paglia, Diana ^b   Kondo, Seiji ^b   Sauder, Daniel N ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

cytokines; leukocytes; skin

Indexed keywords

INTERLEUKIN 1ALPHA; LEUKEMIA INHIBITORY FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION;

ANALYSIS OF VARIANCE; ANIMALS; EAR, EXTERNAL; FEMALE; GROWTH INHIBITORS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LEUKOCYTES; LYMPHOKINES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; SKIN;

EID: 0029866652     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gearing, D. The leukemia inhibitory factor and its receptor. Adv Immunol 1993; 53: 51-58.
2. Metcalf D. Leukemia inhibitory factor-a puzzling polyfunctional regulator. Growth Factors 1992; 7: 169-173.
3. Gough NM. Molecular genetics of leukemia inhibitory factor (LIF) and its receptor. Growth Factors 1992; 7: 175-179.
4. Ryffel B. Pathology induced by leukemia inhibitory factor. Int Rev Exp Pathol 1993; 34pt B: 69-72.
5. Mori M, Yamaguchi K, Honda S, Nagasaki K, Veda M, Abe O, Abe K. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia inhibitory factor. Cancer Res 1991; 51: 6656-6659.
6. Alexander H R, Billingsley KG, Block MI, Fraker DL. D-factor/leukemia inhibitory factor: evidence for its role as a mediator in acute and chronic inflammatory disease. Cytokine 1994; 6: 589-596.
7. Marshall JS, Gauldie J, Nielsen L, Bienenstock J. Leukemia inhibitory factor production by rat mast cells. Eur J Immunol 1993; 23: 21116-21120.
8. Baumann H, Wong GG. Hepatocyte-stimulating factor III shares structural and functional identity with leukemia inhibitory factor. J Immunol 1989; 143: 1163-1167.
9. Paglia D, Oran A, Lu C, Kerbel RS, Sauder DN, Mckenzie RC. Expression of leukemia inhibitory factor and interleukin-11 in human melanoma lines: LIF, IL-6 and IL-11 are not co-regulated. J Interferon Cytokine Res 1995; 14: 455-460.
10. Kondo S, Kono T, Brown WR, Pastore S, Mckenzie RC, Sauder DN. Lymphocyte function-associated antigen-1 is required for maximum elicitation of allergic contact dermatitis. Br J Dermatol 1994; 131: 354-359.
11. Granstein RD, Margolis R, Mizel SB, Sauder DN. In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin-1 in the mouse. J Clin Invest 1986; 77: 1020-1027.
12. Dowd P, Camp RDR, Greaves MW. Human recombinant interleukin-1α is proinflammatory in normal human skin. Skin Pharmacol 1988; 1: 30-37.
13. Larsen, CG, Anderson, AO, Appella, E, Oppenheim JJ, Matsushima, K. The neutrophil-activating protein (NAP-1) is also chemotactic for T-lymphocytes. Science 1989; 243: 1464-1466.
14. Miossec P, Yu CL, Ziff M. Lymphocyte chemotactic activity of interleukin-1. J Immunol 1983; 133: 2007-2011.
15. Jonakait G M. Neural-immune interactions in sympathetic ganglia. Trends Neurosci 1993; 16: 419-423.
16. Barnard W, Bower J, Brown MA, Murphy M, Austin L. Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses LIF mRNA. J Neuro Sci 1994; 123: 108-113.